CELLTRION USA, Inc.

NDC#

• Vegzelma

  CELLTRION USA, Inc.

  bevacizumab-adcd

• Vegzelma

  CELLTRION USA, Inc.

  bevacizumab-adcd

• Adalimumab

  CELLTRION USA, Inc.

  adalimumab-aaty

• Yuflyma

  CELLTRION USA, Inc.

  adalimumab-aaty

• STEQEYMA

  CELLTRION USA, Inc.

  ustekinumab-stba

• STEQEYMA

  CELLTRION USA, Inc.

  ustekinumab-stba

• STEQEYMA

  CELLTRION USA, Inc.

  ustekinumab-stba

• Yuflyma

  CELLTRION USA, Inc.

  adalimumab-aaty

• OMLYCLO

  CELLTRION USA, Inc.

  omalizumab-igec

• OMLYCLO

  CELLTRION USA, Inc.

  omalizumab-igec

• Stoboclo

  CELLTRION USA, Inc.

  denosumab-bmwo

• Osenvelt

  CELLTRION USA, Inc.

  denosumab-bmwo

• Adalimumab

  CELLTRION USA, Inc.

  adalimumab-aaty

• Adalimumab

  CELLTRION USA, Inc.

  adalimumab-aaty

• AVTOZMA

  CELLTRION USA, Inc.

  tocilizumab

• AVTOZMA

  CELLTRION USA, Inc.

  tocilizumab

• AVTOZMA

  CELLTRION USA, Inc.

  tocilizumab

• AVTOZMA

  CELLTRION USA, Inc.

  tocilizumab

• Tocilizumab-anoh

  CELLTRION USA, Inc.

  tocilizumab-anoh

• OMLYCLO

  CELLTRION USA, Inc.

  omalizumab-igec

• Denosumab-BMWO

  CELLTRION USA, Inc.

  denosumab-bmwo

• Denosumab-BMWO

  CELLTRION USA, Inc.

  denosumab-bmwo

• STEQEYMA

  CELLTRION USA, Inc.

  ustekinumab-stba